av/inflarx--big.svg

DE:INFLARX

InflaRx

  • Stock

Last Close

2.04

21/11 21:00

Market Cap

121.30M

Beta: -

Volume Today

312.81K

Avg: -

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory...Show More

competitor of